2025-04-13 - Analysis Report
## Newmont Corporation (NEM) Stock Analysis Report

**0. Key Figures & Initial Analysis:**

Newmont Corporation (NEM) is a leading gold and copper mining company.  The provided data shows a significant underperformance compared to the S&P 500 (VOO) over the analyzed period.

**1. Performance Comparison with S&P 500:**

* **NEM Cumulative Return:** 32.11%
* **VOO Cumulative Return:** 66.36%
* **Return Difference:** -34.2%
* **Relative Deviation:** 26.1% (This indicates NEM's performance is in the 26.1 percentile of its historical performance relative to the S&P 500, based on the provided min/max range.  It is not a measure of absolute outperformance.)


The provided Alpha and Beta data show varying performance relative to the market (S&P 500) over different periods.  While some periods show positive alpha (outperformance), others show negative alpha and increasing beta (higher volatility relative to the market), especially in the most recent years.  The high negative CAGR in recent years (-42%, -70%, -11%) is concerning.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 33.0% | 26.5% | 4.0% | 0.0 | 33.9 |
| 2016-2018  | 17.0% | 58.8% | -1.0% | -0.0 | 31.8 |
| 2017-2019  | -2.0% | 58.8% | -31.0% | -0.1 | 41.5 |
| 2018-2020  | 34.0% | 58.8% | 9.0% | 0.0 | 58.3 |
| 2019-2021  | 71.0% | 59.9% | 17.0% | 0.1 | 62.6 |
| 2020-2022  | -16.0% | 64.3% | -22.0% | 0.2 | 49.6 |
| 2021-2023  | -42.0% | 71.4% | -59.0% | 0.6 | 45.2 |
| 2022-2024  | -70.0% | 75.3% | -87.0% | 0.7 | 41.7 |
| 2023-2025  | -11.0% | 77.0% | -25.0% | 1.4 | 62.0 |


**2. Recent Price Movement:**

* **Closing Price:** $54.97
* **5-Day Moving Average:** $48.90
* **20-Day Moving Average:** $47.95
* **60-Day Moving Average:** $45.14

The recent price of $54.97 represents a significant increase from the previous close ($50.94), indicating a sharp upward movement.  The price is above all three moving averages, suggesting potential short-term momentum.


**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)  This suggests caution.
* **RSI:** 72.40 (Overbought territory, indicating potential for a price correction)
* **PPO:** 0.93 (Positive, suggesting upward momentum)
* **Relative Strength Change (20-day):** +2.9 (Short-term upward trend)

The large price change (`{'price': 54.97, 'previousClose': 50.94, 'change': 7.91}`) reflects a significant recent price jump, possibly indicating a short-covering rally or a shift in market sentiment. The negative expected return of -46.1% in a long-term (2+ years)  horizon relative to the S&P 500 indicates caution.  This is further supported by the high risk MRI.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-24 | 0.8  | $4.61 B       |
| 2024-07-25 | 0.74 | $4.40 B       |
| 2024-04-29 | 0.15 | $4.02 B       |
| 2023-10-26 | 0.2  | $2.49 B       |
| 2024-10-24 | 0.2  | $2.49 B       |  *(Duplicate entry, likely an error)*


There is an apparent discrepancy in the data (duplicate entry for Oct 24, 2024).  Revenue shows a general upward trend, but EPS is volatile.  Further investigation is needed to clarify the data inconsistencies.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $5.65B | 45.51% |
| 2024-09-30 | $4.61B | 36.13% |
| 2024-06-30 | $4.40B | 37.35% |
| 2024-03-31 | $4.02B | 31.39% |
| 2023-12-31 | $3.96B | 24.59% |

Revenue shows growth, and profit margin is relatively high but fluctuates.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $29.93B | 4.69% |
| 2024-09-30 | $29.71B | 3.10% |
| 2024-06-30 | $29.38B | 2.90% |
| 2024-03-31 | $28.89B | 0.59% |
| 2023-12-31 | $29.03B | -10.88% |

Equity is generally increasing, but ROE is quite volatile, indicating potential variability in profitability.


**6. Overall Conclusion:**

NEM has shown significant underperformance against the S&P 500 over the long term. Recent short-term price action suggests a possible rally. However,  high risk indicators (MRI, RSI), a negative long-term expected return relative to the S&P 500,  and volatile earnings and ROE warrant caution.  The data inconsistencies require further investigation.  A thorough review of the company's fundamentals and future prospects is crucial before making any investment decisions. The provided data alone does not suggest a strong buy recommendation.
